Perioperative Research Into Memory: Cognitive Outcome Following Major Burns
NCT ID: NCT03470844
Last Updated: 2018-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2015-08-05
2017-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Inclusion criteria; patients who survive their burns injury (greater than 15% total body surface area) and require mechanical ventilation. Primary exclusion criteria; admission with toxic epidermal necrolysis syndrome, and evidence of head trauma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery
NCT01881646
Postoperative Neurocognitive Disorders
NCT04244162
Patients Experiences of Early Postoperative Cognition
NCT05361460
Prognostic Factors Associated With Postoperative Cognitive Dysfunction After Surgery
NCT03443440
Delirium After Cardiac Surgery in Intensive Care Units
NCT06355570
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5-10 years post severe burn injury
Interventions:
* Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function.
* Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire.
* fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL.
* Quality of Life Self-Assessment data.
Face-to-face neurocognitive tests
Assessment of attention, processing speed, working memory and executive function
Psychological screening
Screening for the symptoms of depression, anxiety and post-traumatic stress disorder
fMRI
Brain volume, chemical markers, functional outcome
Quality of Life Self-Assessment data
EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs
2-5 years post severe burn injury
Interventions:
* Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function.
* Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire.
* fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL.
* Quality of Life Self-Assessment data.
Face-to-face neurocognitive tests
Assessment of attention, processing speed, working memory and executive function
Psychological screening
Screening for the symptoms of depression, anxiety and post-traumatic stress disorder
fMRI
Brain volume, chemical markers, functional outcome
Quality of Life Self-Assessment data
EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs
1-2 years post severe burn injury
Interventions:
* Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function.
* Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire.
* fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL.
* Quality of Life Self-Assessment data.
Face-to-face neurocognitive tests
Assessment of attention, processing speed, working memory and executive function
Psychological screening
Screening for the symptoms of depression, anxiety and post-traumatic stress disorder
fMRI
Brain volume, chemical markers, functional outcome
Quality of Life Self-Assessment data
EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs
Control
Healthy age, gender, socioeconomic and educational level matched control.
Interventions:
* Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function.
* Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire.
* fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL.
* Quality of Life Self-Assessment data.
Face-to-face neurocognitive tests
Assessment of attention, processing speed, working memory and executive function
Psychological screening
Screening for the symptoms of depression, anxiety and post-traumatic stress disorder
fMRI
Brain volume, chemical markers, functional outcome
Quality of Life Self-Assessment data
EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Face-to-face neurocognitive tests
Assessment of attention, processing speed, working memory and executive function
Psychological screening
Screening for the symptoms of depression, anxiety and post-traumatic stress disorder
fMRI
Brain volume, chemical markers, functional outcome
Quality of Life Self-Assessment data
EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with toxic epidermal necrolysis syndrome or evidence of head trauma.
* Patients with evidence of risk to psychological safety from inclusion in study: any patient currently held under section of the Mental Health Act, any patient receiving formal psychiatric treatment (including involvement in a Personality Disorder Unit, being under voluntary section, current re-occurrence of chronic self harm), any patient currently detained at her Majesty's pleasure, any current substance abuse, or at the discretion of professional opinion following historical assessment of notes. - Patients with contraindications to MRI (patients with non-compatible pacemakers, patients with metallic foreign bodies e.g. metal sliver in their eye, patients with non-compatible surgical metal work, patients with severe claustrophobia).
* Patient refusal or inability to give full informed consent.
* Patients unable to understand plain verbal or written English.
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College Healthcare NHS Trust
OTHER
University of Westminster
OTHER
Chelsea and Westminster NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcela P. Vizcaychipi
Planned Care Surgery & Clinical Support Divisional Research Lead
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcela Vizcaychipi, MD PhD FRCA
Role: STUDY_CHAIR
Chelsea and Westminster Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Burn Intensive Care Unit (BICU), Chelsea and Westminster Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C&W13/099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.